These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1267495)

  • 21. [Therapy of coma in liver cirrhosis].
    Manenti F; Ferrari A
    Clin Ter; 1975 Jul; 74(1):3-12. PubMed ID: 1222514
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of hepatic coma].
    Franken FH
    Med Monatsschr; 1973 Sep; 27(9):386-9. PubMed ID: 4588487
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of 3,4-dihydroxyphenylalanine (levodopa) in hepatic coma].
    González-Posada J; Hernández-Peniche J; Tirado-Arroyave S
    Arch Invest Med (Mex); 1972; 3(1):1-6. PubMed ID: 5037838
    [No Abstract]   [Full Text] [Related]  

  • 25. Levodopa in the treatment of hepatic coma due to fulminant hepatic failure.
    Mehta JM; Karamarkar SG; Pimparkar BD; Sheth UK
    J Postgrad Med; 1976 Jan; 22(1):32-6. PubMed ID: 966185
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of L-dopa on hepatic coma].
    Jorge AD; Sanchez D
    Schweiz Rundsch Med Prax; 1973 Jul; 62(27):868-72. PubMed ID: 4578027
    [No Abstract]   [Full Text] [Related]  

  • 27. [Criteria for intensive treatment of hepatic coma].
    Ruffo A; Motta G
    Minerva Med; 1976 Mar; 67(14):861-79. PubMed ID: 944403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Eliciting factors and clinical picture of hepatic coma in 152 patients with cirrhosis of the liver (author's transl)].
    Müting D; Sommer A
    MMW Munch Med Wochenschr; 1979 Mar; 121(13):453-6. PubMed ID: 107423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasmapheresis in the treatment of hepatic coma complicating viral hepatitis].
    Sciborski R; Zubkiewicz-Usnarska L; Groehlich B; Burska-Urbanowicz A; Simon K
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):260-2. PubMed ID: 1437726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neostigmine and polyethylene glycol electrolyte solution for the therapy of acute hepatic encephalopathy with liver cirrhosis and ascites.
    Kiba T; Numata K; Saito S
    Hepatogastroenterology; 2003; 50(51):823-6. PubMed ID: 12828094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.
    Strauss E; Tramote R; Silva EP; Caly WR; Honain NZ; Maffei RA; de Sá MF
    Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of hepatic coma using extracorporeal perfusion with baboon and human liver as well as with activated charcoal].
    Lie TS; Gütgemann A; Siedeck M; Rommelsheim K; Müller J; Dengler HJ; Lelbach WK
    Langenbecks Arch Chir; 1976; Suppl():99-103. PubMed ID: 1031836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa in hepatic coma.
    Parkes JD; Sharpstone P; Williams R
    Lancet; 1970 Dec; 2(7687):1341-3. PubMed ID: 4098911
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepatic encephalopathies; hemodynamic and metabolic study of the influence of ammonia and levodopa].
    Baldy-Moulinier M; Bories P; Michel H; Passouant P
    Rev Neurol (Paris); 1977 Mar; 133(3):175-89. PubMed ID: 918461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-dopa and benserazide in the treatment of acute hepatic encephalopathy in infancy.
    Sinniah D; Chan LL
    Singapore Med J; 1980 Aug; 21(4):658-60. PubMed ID: 7221579
    [No Abstract]   [Full Text] [Related]  

  • 38. Arousal response in hepatic encephalopathy with L-Dopa.
    Weiss A; Pitman ER; Javdan P
    Am J Gastroenterol; 1974 Dec; 62(6):497-503. PubMed ID: 4447098
    [No Abstract]   [Full Text] [Related]  

  • 39. [A corrector of the metabolism of colonic bacteria: modern treatment of portacaval encephalopathies].
    Lande M; Clot C
    Sem Ther; 1968 Dec; 44(10):672-4. PubMed ID: 5706296
    [No Abstract]   [Full Text] [Related]  

  • 40. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.